FDA Clearance Tracker · P170032-S017
Woven EndoBridge Aneurysm Embolization (WEB) System
Last checked: Nov 20, 2026Latest source record: Sep 23, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Sep 23, 2024
Approved
Time to decision
31 days
Received Aug 23, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P170032-S017
- Device name
- Woven EndoBridge Aneurysm Embolization (WEB) System
- Applicant
- MicroVention, Inc.
- Applicant location
- Aliso Viejo, CA
- Received
- Aug 23, 2024
- Decided
- Sep 23, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P170032
Device type
- Device type
- Intrasaccular Flow Disruption Device (OPR)
- Device class
- Class III
- Specialty
- Neurology & Neurosurgery
FDA's approval statement
As written in FDA's record.
approval of the revised protocol for the post-approval study (PAS) referenced above. The revised PAS protocol has been submitted to comply with the conditions of approval outlined in our December 31, 2018, approval order for P170032
Source documents
Other decisions for MicroVention, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254035 · Decided Sep 3, 2026 · 261 days after receipt
Device type: Aspiration Thrombectomy Catheter (QEZ) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.